Cynata Therapeutics Limited

ASX:CYP Stock Report

Market Cap: AU$38.4m

Cynata Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

ASX:CYP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Nov 23BuyAU$12,439Kilian KellyIndividual94,143AU$0.13

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CYP?
Owner TypeNumber of SharesOwnership Percentage
Private Companies00%
Public Companies8,088,4034.48%
Institutions9,506,6255.26%
Individual Insiders12,035,1116.66%
VC/PE Firms23,588,04013.1%
General Public127,458,09270.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 17 shareholders own 29.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.1%
Bioscience Managers Pty Ltd
23,588,040AU$5.0m0%78.73%
5.26%
Fidelity International Ltd
9,506,625AU$2.0m0%no data
4.48%
FUJIFILM Holdings Corporation
8,088,403AU$1.7m0%no data
1.11%
Ross MacDonald
2,000,000AU$425.0k0%no data
0.96%
Craig Darby
1,729,477AU$367.5k55.8%no data
0.86%
Malcolm Washer
1,559,534AU$331.4k0%no data
0.74%
Patrick Walsh
1,341,790AU$285.1k0%no data
0.66%
Makysm Vodyanyk
1,191,658AU$253.2k0%no data
0.43%
Miroslawa Rej
771,518AU$163.9k0%no data
0.43%
Pawel Rej
771,518AU$163.9k0%no data
0.36%
Jon Bjarnason
655,517AU$139.3k9.25%no data
0.36%
Rina Bjarnason
655,517AU$139.3k9.25%no data
0.34%
Kilian Kelly
619,651AU$131.7k0%no data
0.17%
Paul Wotton
315,309AU$67.0k0%no data
0.14%
Geoffrey Edward Brooke
257,343AU$54.7k0%no data
0.064%
Janine Rolfe
116,279AU$24.7k0%no data
0.028%
Darryl Maher
50,000AU$10.6k0%no data